Cargando…

The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome

Sézary syndrome is an aggressive leukemic variant of cutaneous T-cell lymphomas, characterized by erythroderma, lymphadenopathy, and peripheral blood involvement by CD4+ malignant T-cells. The pathogenesis of Sézary syndrome is not fully understood. However, the course of the disease is strongly inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyashiro, Denis, Souza, Bruno de Castro e, Torrealba, Marina Passos, Manfrere, Kelly Cristina Gomes, Sato, Maria Notomi, Sanches, José Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781892/ https://www.ncbi.nlm.nih.gov/pubmed/35055124 http://dx.doi.org/10.3390/ijms23020936

Ejemplares similares

Double-positive CD4 and CD8 Sézary syndrome
por: Miyashiro, Denis, et al.
Publicado: (2017)

Chronic activation profile of circulating CD8+ T cells in Sézary syndrome
por: Torrealba, Marina Passos, et al.
Publicado: (2017)

Imbalanced IL-1B and IL-18 Expression in Sézary Syndrome
por: Manfrere, Kelly Cristina Gomes, et al.
Publicado: (2023)

Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome
por: ManfrereC, Kelly C.G., et al.
Publicado: (2017)

Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome
por: Manfrere, Kelly C. G., et al.
Publicado: (2016)

Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management
por: Miyashiro, Denis, et al.
Publicado: (2023)

Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario()()
por: Sanches, José Antonio, et al.
Publicado: (2021)

The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome
por: Liu, Zhaorui, et al.
Publicado: (2021)

Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression
por: Dobos, Gabor, et al.
Publicado: (2023)

Alemtuzumab in refractory Sézary syndrome
por: Reifs, Carmen María Alcántara, et al.
Publicado: (2016)

The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications
por: Pileri, Alessandro, et al.
Publicado: (2021)

Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice
por: Gao, Jie, et al.
Publicado: (2023)

Plantar keratoderma of Sézary syndrome
por: Fragkos, Konstantinos C.
Publicado: (2017)

Mycosis fungoides and Sézary syndrome
por: Jonak, Constanze, et al.
Publicado: (2021)

Mycosis fungoides and Sézary syndrome
por: Lee, Hyewon
Publicado: (2023)

Dupilumab-Associated Sezary Syndrome
por: Hamp, Austin, et al.
Publicado: (2023)

Pembrolizumab-associated tumor development in a patient with Sézary syndrome
por: Malachowski, Stephen J., et al.
Publicado: (2019)

Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome
por: Moerman-Herzog, Andrea, et al.
Publicado: (2020)

Cutaneous metastases from solid neoplasms – Literature review()
por: Souza, Bruno de Castro e, et al.
Publicado: (2023)

Integrated Genomic Analysis of Sézary Syndrome
por: Mao, Xin, et al.
Publicado: (2011)

A mouse model for the Sézary syndrome
por: Doebbeling, Udo
Publicado: (2010)

The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015)

Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
por: Afiat, Thanh-Phuong, et al.
Publicado: (2018)

TOX Expression in Mycosis Fungoides and Sezary Syndrome
por: Pileri, Alessandro, et al.
Publicado: (2022)

Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
por: Saulite, Ieva, et al.
Publicado: (2016)

Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
por: Maredia, Hasina, et al.
Publicado: (2021)

Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome
por: Kawana, Yuki, et al.
Publicado: (2021)

EPHA4 is overexpressed but not functionally active in Sézary syndrome
por: Hameetman, Liesbeth, et al.
Publicado: (2015)

New Insights Into the Complex Mutational Landscape of Sézary Syndrome
por: Mirza, Abu-Sayeef, et al.
Publicado: (2020)

Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome
por: Robertson, Jake C, et al.
Publicado: (2021)

Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center
por: Miyashiro, Denis, et al.
Publicado: (2020)

Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome
por: Caprini, Elisabetta, et al.
Publicado: (2018)

Peripheral Neuropathy in Sézary Syndrome: Coincidence or a Part of the Syndrome?
por: Karadağ, Yeşim S., et al.
Publicado: (2013)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYCOSIS FUNGOIDES AND SEZARY SYNDROME
por: Lechowicz, Mary Jo, et al.
Publicado: (2014)

Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
por: Vural, Seçil, et al.
Publicado: (2018)

Images from the Haematologica Atlas of Hematologic Cytology: Sézary syndrome
por: Invernizzi, Rosangela
Publicado: (2022)

Sézary syndrome originates from heavily mutated hematopoietic progenitors
por: Harro, Carly M., et al.
Publicado: (2023)

Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome
por: Cristofoletti, Cristina, et al.
Publicado: (2022)

The Treatment of Advanced-Stage Mycosis Fungoides and Sezary Syndrome: a Hematologist’s Point of View
por: Giordano, Antonio, et al.
Publicado: (2022)

Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update()
por: Yamashita, Thamy, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0s5t8sdtnabd06bq043lq8145k